Literature DB >> 12619886

The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori.

Archana Chatterjee1, Taharat Yasmin, Debasis Bagchi, Sidney J Stohs.   

Abstract

Chronic infection with Helicobacter pylori causes peptic ulcers, gastric cancer and lymphoma. We evaluated the inhibitory effects of the probiotic Lactobacillus acidophilus DDS-1J, the antibiotic clarithromycin and the natural antioxidants garcinol and Protykin (containing 50% trans-resveratrol) on Helicobacter pylori strain ATCC 49503. The findings of this study indicate that Lactobacillus acidophilus DDS-1J exerts a growth inhibitory effect on H. pylori at a ratio of 1:1 or higher in vitro. In the case of clarithromycin, garcinol and resveratrol, the bactericidal effect is time and concentration dependent. Clarithromycin completely inhibited growth at > or = 62.5 microg/ml at 6 h and at > or = 31.5 microg/ml at 12 h. For garcinol the highest concentration needed for complete inhibition was 31.5 microg/ml at 6 h and 3.9 microg/ml after 12 h incubation. For resveratrol, significant inhibition was noted at 1000 microg/ml at 12 h only. The bactericidal effect of garcinol was reduced by the addition of resveratrol at all concentrations < or = 125 microg/ml at 6 and 12 h. We conclude from this study that Lactobacillus acidophilus DDS-1J inhibits H. pylori at 1:1 and higher ratios. Also, between the two antioxidants, garcinol is much more potent than resveratrol as a bactericidal agent against H. pylori, and that resveratrol may antagonize this effect. Finally, our study showed equivalent or better bactericidal activity of garcinol compared to clarithromycin against H. pylori at 6 and 12 h incubation, indicating a potential role for this antioxidant in treatment for H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619886     DOI: 10.1023/a:1021649427988

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

Review 1.  Helicobacter pylori: an overview.

Authors:  M Wilkinson
Journal:  Br J Biomed Sci       Date:  2001       Impact factor: 3.829

Review 2.  [Helicobacter pylori & gastric disease].

Authors:  T Kozu; D Saito
Journal:  Rinsho Byori       Date:  2001-02

3.  Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

Authors:  C P Felley; I Corthésy-Theulaz; J L Rivero; P Sipponen; M Kaufmann; P Bauerfeind; P H Wiesel; D Brassart; A Pfeifer; A L Blum; P Michetti
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-01       Impact factor: 2.566

4.  In vitro antibacterial activity of Chilean red wines against Helicobacter pylori.

Authors:  F Daroch; M Hoeneisen; C L González; F Kawaguchi; F Salgado; H Solar; A García
Journal:  Microbios       Date:  2001

Review 5.  The carcinogenic effect of H. pylori on the gastric epithelial cell.

Authors:  S F Moss
Journal:  J Physiol Pharmacol       Date:  1999-12       Impact factor: 3.011

Review 6.  Role of reactive oxygen species in intestinal diseases.

Authors:  A van der Vliet; A Bast
Journal:  Free Radic Biol Med       Date:  1992       Impact factor: 7.376

7.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

8.  The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration.

Authors:  A S Salim
Journal:  Intern Med       Date:  1993-05       Impact factor: 1.271

9.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

10.  Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221.

Authors:  B Bogovic-Matijasić; I Rogelj; I F Nes; H Holo
Journal:  Appl Microbiol Biotechnol       Date:  1998-05       Impact factor: 4.813

View more
  17 in total

1.  Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bokyung Sung; Manoj K Pandey; Bharat B Aggarwal
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

2.  Garcinol Suppresses IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via Inhibition of the NF-κB Signaling Pathway.

Authors:  Yewei Jia; Cong Pang; Kangxian Zhao; Jiawei Jiang; Tan Zhang; Jiaxuan Peng; Peng Sun; Yu Qian
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

3.  Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.

Authors:  Archana Chatterjee; Debasis Bagchi; Taharat Yasmin; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

4.  Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice.

Authors:  Kathene Candace Johnson-Henry; David J Mitchell; Yaron Avitzur; Esther Galindo-Mata; Nicola L Jones; Philip M Sherman
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Effects of histone acetyltransferase inhibitors on L-DOPA-induced dyskinesia in a murine model of Parkinson's disease.

Authors:  Young-Kyoung Ryu; Hye-Yeon Park; Jun Go; Yong-Hoon Kim; Jung Hwan Hwang; Dong-Hee Choi; Jung-Ran Noh; Myungchull Rhee; Pyung-Lim Han; Chul-Ho Lee; Kyoung-Shim Kim
Journal:  J Neural Transm (Vienna)       Date:  2018-07-11       Impact factor: 3.575

6.  Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin.

Authors:  Archana Chatterjee; Taharat Yasmin; Debasis Bagchi; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

Review 7.  Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs.

Authors:  Subhash Padhye; Aamir Ahmad; Nikhil Oswal; Fazlul H Sarkar
Journal:  J Hematol Oncol       Date:  2009-09-02       Impact factor: 17.388

8.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09

9.  Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.

Authors:  Feng Li; Muthu K Shanmugam; Kodappully Sivaraman Siveen; Fan Wang; Tina H Ong; Ser Yue Loo; Mahadeva M M Swamy; Somnath Mandal; Alan Prem Kumar; Boon Cher Goh; Tapas Kundu; Kwang Seok Ahn; Ling Zhi Wang; Kam Man Hui; Gautam Sethi
Journal:  Oncotarget       Date:  2015-03-10

10.  Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model.

Authors:  N Subhasree; Ananthkumar Kamella; Ilango Kaliappan; Aruna Agrawal; Govind Prasad Dubey
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.